机构

• 合肥物质科学研究院 [6]
• 深圳先进技术研究院 [2]
• 上海药物研究所 [1]

采集方式

• OAI收割 [9]

内容类型

• 期刊论文 [8]
• 会议论文 [1]

发表日期

• 2022 [2]
• 2021 [4]
• 2020 [1]
• 2018 [1]
• 2016 [1]

学科主题

筛选

浏览/检索结果: 共9条，第1-9条 帮助 条数/页： 5101520253035404550556065707580859095100 排序方式： 请选择提交时间升序提交时间降序发表日期升序发表日期降序题名升序题名降序作者升序作者降序 Serplulimab, a novel anti-PD-1 antibody, in patients with microsatellite instability-high solid tumours: an open-label, single-arm, multicentre, phase II trial 期刊论文  OAI收割 BRITISH JOURNAL OF CANCER, 2022 作者:  Qin, Shukui;  Li, Jin;  Zhong, Haijun;  Jin, Chuan;  Chen, Lili   |  收藏  |  浏览/下载：20/0  |  提交时间：2022/12/22 Systemic Therapy for Hepatocellular Carcinoma: Chinese Consensus-Based Interdisciplinary Expert Statements 期刊论文  OAI收割 LIVER CANCER, 2022, 卷号: 11 作者:  Sun, Yongkun;  Zhang, Wen;  Bi, Xinyu;  Yang, Zhengqiang;  Tang, Yu   |  收藏  |  浏览/下载：37/0  |  提交时间：2022/12/23 Chinese interdisciplinary experts  Hepatocellular carcinoma  Molecular targeted therapy  Consensus   Apatinib vs Placebo in Patients With Locally Advanced or Metastatic, Radioactive Iodine-Refractory Differentiated Thyroid Cancer The REALITY Randomized Clinical Trial 期刊论文  OAI收割 JAMA ONCOLOGY, 2021 作者:  Lin, Yansong;  Qin, Shukui;  Li, Zhiyong;  Yang, Hui;  Fu, Wei   |  收藏  |  浏览/下载：63/0  |  提交时间：2022/01/25 Safety and efficacy of apatinib as third or later line treatment for advanced gastric cancer or gastroesophageal junction adenocarcinoma: A post-marketing phase IV study. 期刊论文  OAI收割 JOURNAL OF CLINICAL ONCOLOGY, 2021, 卷号: 39 作者:  Li, Jin;  Qin, Shukui;  Wen, Lu;  Wang, Junsheng;  Deng, Wenying   |  收藏  |  浏览/下载：25/0  |  提交时间：2022/01/10 Efficacy and safety of HLX10, a novel anti-PD-1 antibody, in patients with previously treated unresectable or metastatic microsatellite instability-high or mismatch repair-deficient solid tumors: A single-arm, multicenter, phase 2 study. 期刊论文  OAI收割 JOURNAL OF CLINICAL ONCOLOGY, 2021, 卷号: 39 作者:  Qin, Shukui;  Li, Jin;  Zhong, Haijun;  Jin, Chuan;  Chen, Lili   |  收藏  |  浏览/下载：31/0  |  提交时间：2022/01/10 Clinical effectiveness of apatinib at different doses in patients with advanced gastric cancer as the third-line or further treatment: Results from a post-marketing phase IV study. 期刊论文  OAI收割 JOURNAL OF CLINICAL ONCOLOGY, 2021, 卷号: 39 作者:  Li, Jin;  Qin, Shukui;  Wen, Lu;  Wang, Junsheng;  Deng, Wenying   |  收藏  |  浏览/下载：14/0  |  提交时间：2022/01/10 Safety, Clinical Activity, and Pharmacokinetics of Al flutinib (AST2818) in Patients With Advanced NSCLC With EGFR T790M Mutation 期刊论文  OAI收割 JOURNAL OF THORACIC ONCOLOGY, 2020, 卷号: 15, 期号: 6, 页码: 1015-1026 作者:  Shi, Yuankai;  Zhang, Shucai;  Hu, Xingsheng;  Feng, Jifeng;  Ma, Zhiyong   |  收藏  |  浏览/下载：82/0  |  提交时间：2020/12/24 Alflutinib  NSCLC  EGFR T790M mutation  Efficacy  Safety   Porous composite scaffold incorporating osteogenic phytomolecule Icariin for promoting skeletal regeneration in challenging osteonecrotic bone in rabbits 期刊论文  OAI收割 Biomaterials, 2018 作者:  Yuxiao Lai;  Huijuan Cao;  Xinluan Wang;  Shukui Chen;  Ming Zhang   |  收藏  |  浏览/下载：42/0  |  提交时间：2018/02/02 Icariin incorporated into a porous scaffold promotes reparative osteogenesis in vitro and in vivo 会议论文  OAI收割 2016 International Combined Meeting of Orthopaedic, 西安 作者:  Huijuan Cao;  Shukui Chen;  Ming Zhang;  Nan Wang;  Long Li 收藏  |  浏览/下载：14/0  |  提交时间：2017/01/15